KVP Capital Advisors, LP
Long book
$133.9M
Q1 2026
Positions
32
Top-10 weight
61%
concentration
Last quarter
+21.5%
SPY +14.8%
Turnover
32%
of book per quarter
Strategy in plain words
auto-generated from filingsKVP Capital Advisors, LP is a concentrated fundamental stock-picker, specialised in healthcare (99% of the long book), running a $133.9M US long book across 32 positions.
The portfolio is concentrated: the top 10 names carry 61% of the portfolio. The portfolio is actively managed, with meaningful quarterly turnover. Current anchor positions: TERNS PHARMACEUTICALS INC, PRAXIS PRECISION MEDICINES I, WHITEHAWK THERAPEUTICS INC, AXSOME THERAPEUTICS INC, SUTRO BIOPHARMA INC.
We rate its filings highest-signal: new buys here are worth attention.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q4 2025
+5.4%
Q1 2026
+21.5%
Sector allocation
Healthcare 80%
Other 19%
Materials 1%
Long book by quarter
What does KVP Capital own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| 430 TERNS PHARMACEUTICALS INC | — | 440.0K | $23.2M | 17.3% | Held |
| PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 42.9K | $13.8M | 10.3% | Held |
| WHWK WHITEHAWK THERAPEUTICS INC | Healthcare | 2.2M | $7.5M | 5.6% | Held |
| AXSM AXSOME THERAPEUTICS INC | Healthcare | 36.2K | $6.1M | 4.6% | Held |
| STRO SUTRO BIOPHARMA INC | Healthcare | 226.6K | $5.6M | 4.2% | New |
| PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 53.0K | $5.6M | 4.2% | Held |
| ERAS ERASCA INC | Healthcare | 340.0K | $5.5M | 4.1% | New |
| TRVI TREVI THERAPEUTICS INC | Healthcare | 414.0K | $4.9M | 3.7% | Held |
| TNGX TANGO THERAPEUTICS INC | Healthcare | 230.3K | $4.8M | 3.6% | New |
| INSM INSMED INC | Healthcare | 28.5K | $4.7M | 3.5% | Held |
| EWTX EDGEWISE THERAPEUTICS INC | Healthcare | 133.0K | $4.2M | 3.1% | Held |
| RVMD REVOLUTION MEDICINES INC | Healthcare | 40.2K | $3.9M | 2.9% | +46.2% |
| IRON DISC MEDICINE INC | Healthcare | 58.3K | $3.7M | 2.8% | Held |
| MBX MBX BIOSCIENCES INC | Healthcare | 121.5K | $3.6M | 2.7% | Held |
| SVRA SAVARA INC | Healthcare | 605.3K | $3.3M | 2.5% | Held |
| UTHR UNITED THERAPEUTICS CORP | Healthcare | 4.8K | $2.8M | 2.1% | Held |
| TVTX TRAVERE THERAPEUTICS INC | Healthcare | 91.0K | $2.7M | 2.0% | Held |
| IDYA IDEAYA BIOSCIENCES INC | Healthcare | 79.7K | $2.7M | 2.0% | New |
| CMPX COMPASS THERAPEUTICS INC | Healthcare | 500.0K | $2.6M | 2.0% | New |
| OCUL OCULAR THERAPEUTIX INC | Healthcare | 300.0K | $2.5M | 1.9% | New |
| VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 125.0K | $2.4M | 1.8% | New |
| DRUG BRIGHT MINDS BIOSCIENCES INC | Healthcare | 31.8K | $2.3M | 1.7% | New |
| ZURA ZURA BIO LTD | Healthcare | 373.1K | $2.2M | 1.7% | New |
| SRRK SCHOLAR ROCK HOLDING CORP | Healthcare | 45.0K | $2.2M | 1.7% | Held |
| IMMX IMMIX BIOPHARMA INC | Healthcare | 230.4K | $2.1M | 1.6% | Held |
| SLNOEUR SOLENO THERAPEUTICS INC | — | 59.7K | $2.0M | 1.5% | Held |
| NKTR NEKTAR THERAPEUTICS | Healthcare | 26.9K | $1.9M | 1.4% | Held |
| CABA CABALETTA BIO INC | Healthcare | 505.4K | $1.4M | 1.0% | Held |
| ACHV ACHIEVE LIFE SCIENCES INC | Materials | 462.4K | $1.4M | 1.0% | Held |
| VERA VERA THERAPEUTICS INC | Healthcare | 32.7K | $1.3M | 1.0% | Held |
| CELC CELCUITY INC | Healthcare | 4.0K | $457K | 0.3% | Held |
| VYNE VYNE THERAPEUTICS INC | Healthcare | 500.6K | $299K | 0.2% | Held |